Cargando…
Natural history of NASH
Non‐alcoholic fatty liver disease (NAFLD) is the fastest growing cause of chronic liver disease worldwide. Although only a small proportion of NAFLD patients will progress to end‐stage liver disease and death, the clinical burden of NAFLD is substantial due the sheer number of individuals affected w...
Autores principales: | Armandi, Angelo, Bugianesi, Elisabetta, Valenti, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361694/ https://www.ncbi.nlm.nih.gov/pubmed/34155792 http://dx.doi.org/10.1111/liv.14910 |
Ejemplares similares
-
Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017) -
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021) -
Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis
por: Rivera‐Esteban, Jesús, et al.
Publicado: (2021) -
Current therapies and new developments in NASH
por: Dufour, Jean-François, et al.
Publicado: (2022) -
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
por: Armandi, Angelo, et al.
Publicado: (2021)